134 related articles for article (PubMed ID: 29951491)
1. Meta-analysis of the association between
Jiang YT; Li HY; Cao XP; Tan L
Ann Transl Med; 2018 May; 6(10):169. PubMed ID: 29951491
[TBL] [Abstract][Full Text] [Related]
2. Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations.
Mao YF; Guo ZY; Pu JL; Chen YX; Zhang BR
Neurosci Lett; 2015 Nov; 609():235-9. PubMed ID: 26455864
[TBL] [Abstract][Full Text] [Related]
3. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
[TBL] [Abstract][Full Text] [Related]
4. Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders.
Wang YJ; Wan Y; Wang HF; Tan CC; Li JQ; Yu JT; Tan L;
J Alzheimers Dis; 2019; 68(2):757-766. PubMed ID: 30883353
[TBL] [Abstract][Full Text] [Related]
5. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
6. CD33 rs3865444 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Chinese, European, and North American Populations.
Li X; Shen N; Zhang S; Liu J; Jiang Q; Liao M; Feng R; Zhang L; Wang G; Ma G; Zhou H; Chen Z; Jiang Y; Zhao B; Li K; Liu G
Mol Neurobiol; 2015 Aug; 52(1):414-21. PubMed ID: 25186233
[TBL] [Abstract][Full Text] [Related]
7. CD33 rs3865444 as a risk factor for Parkinson's disease.
Siokas V; Arseniou S; Aloizou AM; Tsouris Z; Liampas I; Sgantzos M; Liakos P; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
Neurosci Lett; 2021 Mar; 748():135709. PubMed ID: 33582190
[TBL] [Abstract][Full Text] [Related]
8. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease.
Heidari F; Ansstas G; Ajamian F
Gerontology; 2022; 68(4):421-430. PubMed ID: 34569532
[TBL] [Abstract][Full Text] [Related]
9. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
[TBL] [Abstract][Full Text] [Related]
10. Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis.
Bao J; Wang XJ; Mao ZF
Med Sci Monit; 2016 Jan; 22():234-43. PubMed ID: 26795201
[TBL] [Abstract][Full Text] [Related]
11. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility.
Raj T; Ryan KJ; Replogle JM; Chibnik LB; Rosenkrantz L; Tang A; Rothamel K; Stranger BE; Bennett DA; Evans DA; De Jager PL; Bradshaw EM
Hum Mol Genet; 2014 May; 23(10):2729-36. PubMed ID: 24381305
[TBL] [Abstract][Full Text] [Related]
12. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.
Walker DG; Whetzel AM; Serrano G; Sue LI; Beach TG; Lue LF
Neurobiol Aging; 2015 Feb; 36(2):571-82. PubMed ID: 25448602
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's Disease Risk Variant rs3865444 in the
Javor J; Bucová M; Ďurmanová V; Radošinská D; Párnická Z; Čierny D; Kurča E; Čopíková-Cudráková D; Gmitterová K; Shawkatová I
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888182
[TBL] [Abstract][Full Text] [Related]
14. Association of MS4A6A, CD33, and TREM2 gene polymorphisms with the late-onset Alzheimer's disease.
Mehdizadeh E; Khalaj-Kondori M; Shaghaghi-Tarakdari Z; Sadigh-Eteghad S; Talebi M; Andalib S
Bioimpacts; 2019; 9(4):219-225. PubMed ID: 31799158
[No Abstract] [Full Text] [Related]
15. Genome-wide significant risk factors on chromosome 19 and the
Moreno-Grau S; Hernández I; Heilmann-Heimbach S; Ruiz S; Rosende-Roca M; Mauleón A; Vargas L; Rodríguez-Gómez O; Alegret M; Espinosa A; Ortega G; Aguilera N; Abdelnour C; Neuroimaging Initiative AD; Gil S; Maier W; Sotolongo-Grau O; Tárraga L; Ramirez A; López-Arrrieta J; Antúnez C; Serrano-Ríos M; Boada M; Ruiz A
Oncotarget; 2018 May; 9(37):24590-24600. PubMed ID: 29872490
[TBL] [Abstract][Full Text] [Related]
16. Multiple Sclerosis: Shall We Target CD33?
Siokas V; Tsouris Z; Aloizou AM; Bakirtzis C; Liampas I; Koutsis G; Anagnostouli M; Bogdanos DP; Grigoriadis N; Hadjigeorgiou GM; Dardiotis E
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198164
[TBL] [Abstract][Full Text] [Related]
17. Lack of Association between
Siokas V; Liampas I; Aloizou AM; Bakirtzis C; Tsouris Z; Nousia A; Nasios G; Papadimitriou D; Lavdas E; Liakos P; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Integr Neurosci; 2023 Jul; 22(4):106. PubMed ID: 37519183
[TBL] [Abstract][Full Text] [Related]
18. Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study.
Carrasquillo MM; Belbin O; Hunter TA; Ma L; Bisceglio GD; Zou F; Crook JE; Pankratz VS; Sando SB; Aasly JO; Barcikowska M; Wszolek ZK; Dickson DW; Graff-Radford NR; Petersen RC; Passmore P; Morgan K; ; Younkin SG
Mol Neurodegener; 2011 Jul; 6(1):54. PubMed ID: 21798052
[TBL] [Abstract][Full Text] [Related]
19. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease.
Dos Santos LR; Pimassoni LHS; Sena GGS; Camporez D; Belcavello L; Trancozo M; Morelato RL; Errera FIV; Bueno MRP; de Paula F
J Mol Neurosci; 2017 Jun; 62(2):215-221. PubMed ID: 28477215
[TBL] [Abstract][Full Text] [Related]
20. Relationships between CETP genetic polymorphisms and Alzheimer's disease risk: a meta-analysis.
Chen JJ; Li YM; Zou WY; Fu JL
DNA Cell Biol; 2014 Nov; 33(11):807-15. PubMed ID: 25105518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
